News from ESC congress 2019: New ESC/EAS guidelines for dyslipidaemia management published

被引：3
作者：
Stock, Jane [1 ]
机构：
[1] World Trade Ctr Goteborg, European Atherosclerosis Soc, Massans Gata 10, SE-41251 Gothenburg, Sweden
来源：
ATHEROSCLEROSIS | 2019年 / 291卷
关键词：
ESC; 2019; Congress; New guidelines; PCSK9 INHIBITOR EVOLOCUMAB; LOW LDL-CHOLESTEROL; RISK; EFFICACY; DISEASE; SAFETY;
D O I：
10.1016/j.atherosclerosis.2019.09.013
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：124 / 126
页数：3
相关论文
共 50 条
  • [31] Comments on the 2011 ESC/EAS guidelines for the management of dyslipidemias. A report of the Task Force of the Clinical Practice Guidelines Committee of the Spanish Society of Cardiology
    Anguita, Manuel
    Alegria, Eduardo
    Barrios, Vivencio
    Casasnovas, Jose A.
    Escobar, Carlos
    Leon, Monserrat
    Luengo, Emilio
    Llisterri, Jose L.
    REVISTA ESPANOLA DE CARDIOLOGIA, 2011, 64 (12): : 1090 - 1095
  • [32] Lipid and cardiometabolic features of T2DM patients achieving stricter LDL-C and non-HDL-C targets in accordance with ESC/EAS 2019 guidelines
    Hermans, Michel P.
    Ahn, Sylvie A.
    Rousseau, Michel F.
    ACTA CARDIOLOGICA, 2021, 76 (04) : 375 - 383
  • [33] Comments on the 2018 ESC/ESH Guidelines for the Management of Arterial Hypertension
    Mazon, Pilar
    Marin, Francisco
    Cosin-Sales, Juan
    Cordero, Alberto
    Roldan, Inmaculada
    Garcia-Moll, Xavier
    Suarez, Carmen
    Coca, Antonio
    Escobar, Carlos
    Barrios, Vivencio
    Vidal, Rafael
    Diez-Villanueva, Pablo
    Bonanad, Clara
    Esteban, Alberto
    Zuazola, Pilar
    Bertomeu, Vicente
    Abeytua, Manuel
    Zuazola, Pilar
    Alfonso, Fernando
    Ibanez, Borja
    Arribas, Fernando
    Congost, Gemma Berga
    Bueno, Hector
    Evangelista, Arturo
    Ferreira-Gonzalez, Ignacio
    Navarro, Manuel Jimenez
    Marin, Francisco
    de Isla, Leopoldo Perez
    Sambola, Antonia
    Vazquez, Rafael
    Viana-Tejedor, Ana
    REVISTA ESPANOLA DE CARDIOLOGIA, 2019, 72 (02): : 104 - 108
  • [34] The New ESC Guidelines for the Diagnosis and Management of Chronic Coronary Syndromes: the Good and the Not So Good
    Ferrari, Roberto
    Pavasini, Rita
    Censi, Stefano
    Squeri, Angelo
    Rosano, Giuseppe
    CURRENT PROBLEMS IN CARDIOLOGY, 2021, 46 (03)
  • [35] Optimal management of syncope: the new ESC Guidelines and novel insights into its underlying causes
    Luscher, Thomas F.
    EUROPEAN HEART JOURNAL, 2018, 39 (21) : 1865 - 1869
  • [36] The new 2022 ESC Guidelines on Cardio-oncology and their impact on the Acute Cardiovascular Care Society
    von Kemp, Berlinde
    Halvorsen, Sigrun
    Nohria, Anju
    EUROPEAN HEART JOURNAL-ACUTE CARDIOVASCULAR CARE, 2022, 11 (11) : 844 - 849
  • [37] Diabetes, pre-diabetes and cardiovascular diseases in light of the 2019 ESC Guidelines
    Zandecki, Lukasz
    Janion-Sadowska, Agnieszka
    Kurzawski, Jacek
    Janion, Marianna
    MEDICAL STUDIES-STUDIA MEDYCZNE, 2020, 36 (02) : 148 - 155
  • [38] Low-density lipoprotein-cholesterol target attainment according to the 2011 and 2016 ESC/EAS dyslipidaemia guidelines in patients with a recent myocardial infarction: nationwide cohort study, 2013-17
    Allahyari, Ali
    Jernberg, Tomas
    Lautsch, Dominik
    Lundman, Pia
    Hagstrom, Emil
    Schubert, Jessica
    Boggs, Robert
    Salomonsson, Stina
    Ueda, Peter
    EUROPEAN HEART JOURNAL-QUALITY OF CARE AND CLINICAL OUTCOMES, 2021, 7 (01) : 59 - 67
  • [39] Management of Arterial Hypertension: 2018 ACC/AHA Versus ESC Guidelines and Perioperative Implications
    Travieso-Gonzalez, Alejandro
    Nunez-Gil, Ivan J.
    Riha, Hynek
    Garcia Donaire, Jose A.
    Ramakrishna, Harish
    JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 2019, 33 (12) : 3496 - 3503
  • [40] Comments on the guidelines (2018) of the ESC on the management of cardiovascular diseases during pregnancy
    Seeland, U.
    Bauersachs, J.
    Kintscher, U.
    Hilfiker-Kleiner, D.
    Roos-Hesselink, J. W.
    Regitz-Zagrosek, V.
    KARDIOLOGE, 2019, 13 (03): : 138 - 145
12345